Thor Explorations Ltd. (TSXV:THX)

Inozyme Pharma Revenue

Thor Explorations had revenue of $82.79M USD in the quarter ending June 30, 2025, with 53.67% growth. This brings the company's revenue in the last twelve months to $252.80M, up 72.23% year-over-year. In the year 2024, Thor Explorations had annual revenue of $193.13M with 36.73% growth.

• Revenue (ttm): $252.80M
• Revenue Growth: +72.23%
• P/S Ratio: 1.68
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 578.81M

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	193.13M	51.89M	36.73%
Dec 31, 2023	141.25M	-23.93M	-14.49%
Dec 31, 2022	165.17M	159.13M	2,630.39%
Dec 31, 2021	6.05M	-	-
Dec 31, 2020	-	-	-